@article{oai:soar-ir.repo.nii.ac.jp:00008078, author = {Ohira, Satoshi and Miyake, Masako and Kobara, Hisanori and Kikuchi, Norihiko and Osada, Ryosuke and Ashida, Takashi and Hirabayashi, Kanae and Nishio, Shin-ichi and Kanai, Makoto and Shiozawa, Tanri}, issue = {4}, journal = {FETAL DIAGNOSIS AND THERAPY}, month = {}, note = {Most fetal goitrous hypothyroidisms are reportedly caused by the maternal use of an antithyroid drug or fetal dyshormonogenesis. However, fetal goitrous hypothyroidism due to the transplacental passage of maternal thyroid stimulation-blocking antibody (TSBAb) is extremely rare. A woman at 28 weeks of gestation was found to have a fetal goiter by ultrasonography. Because the maternal serum showed hypothyroidism with an elevated titer of TSBAb, levothyroxine sodium was administered. The patient delivered a male infant, 3,412 g, with a goiter at term. Umbilical blood revealed primary hypothyroidism with increased TSBAb, and the infant was given levothyroxine sodium. After a month, neonatal thyroid function and TSBAb levels became normal. Attention should be paid to possible fetal hypothyroidism when a fetal goiter is observed to avoid impaired mental development of the neonate., Article, FETAL DIAGNOSIS AND THERAPY. 28(4):220-224 (2010)}, pages = {220--224}, title = {Fetal Goitrous Hypothyroidism due to Maternal Thyroid Stimulation-Blocking Antibody: A Case Report}, volume = {28}, year = {2010} }